Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1995-05-24
1996-09-24
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
A61K 31255
Patent
active
055591485
ABSTRACT:
Stable parenteral formulations of busulfan for parenteral administration are disclosed. The improved bioavailability of the parenteral formulations optimizes high dose busulfan therapy against malignant disease and improves the safety of such therapy.
REFERENCES:
Bhagwatwar et al., Pharm. Research 9(10), Oct. 1992, S 200.
Bhagwatwar et al., Proceedings of the Am. Assoc. Can. Res., vol. 34, Mar. 1993, p. 269.
Andersson Borje S.
Bhagwatwar Harshal P.
Chow Diana S.
Board of Regents , The University of Texas System
Cintins Marianne M.
Spivack Phyllis G.
University of Houston-University Park
LandOfFree
Parenteral busulfan for treatment of malignant disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Parenteral busulfan for treatment of malignant disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Parenteral busulfan for treatment of malignant disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1928761